https://www.selleckchem.com/pr....oducts/tetramisole-h
lthough it is associated with a nonnegligible toxicity profile. Long-term androgen-deprivation therapy (ADT) is the standard of care in combination with radiation therapy (RT) in high-risk prostate cancer (PC), despite substantial toxicity from the resulting hypogonadism. We hypothesized that a combination of more potent but shorter-term androgen inhibition in men with intermediate- or high-risk localized PC would synergize with definitive RT to provide short-term testosterone recovery and improve disease control. This prospecti
Like
Comment
Share
